VENUS REMEDIES
|
The Current P/S Ratio of VENUS REMEDIES is 0.61.
Share Price | ₹296.2 | Feb 28,2025 |
Market Cap | ₹396.9 Cr | |
Sales-TTM | ₹648.1 Cr | TTM-Consolidated Results |
Price/Sales | 0.61x | Calculated as Market Cap/Sales |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PS (Price/Sales) ratio of VENUS REMEDIES
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹396.9 Cr] as on Feb 28,2025
(/) Sales [ ₹648.1 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 0.61x ]
Thus, for VENUS REMEDIES , the investors are currently willing to pay '0.61 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of VENUS REMEDIES !
The chart below summarizes the trend in P/S Ratio of VENUS REMEDIES over the last five years.
Historical PS (Price/Sales) ratio chart of VENUS REMEDIES
PS Ratio Performance Analysis for VENUS REMEDIES
- VENUS REMEDIES 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 0.48x.
- VENUS REMEDIES 's operated at median p/e ratio of 0.6x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, VENUS REMEDIES 's p/e ratio peaked in Mar2024 at 0.73x.
- VENUS REMEDIES 's p/e ratio hit its five-year low in Mar2020 of 0.08x.
How does VENUS REMEDIES 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
---|---|---|---|
VENUS REMEDIES | 648.1 | 0.61 | 396.9 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 51,602.5 | 7.41 | 382,430.0 |
DIVIS LABORATORIES LTD | 9,078.0 | 16.02 | 145,410.0 |
CIPLA LTD | 26,981.2 | 4.22 | 113,950.0 |
TORRENT PHARMACEUTICALS LTD | 11,302.0 | 8.82 | 99,682.3 |
DR REDDYS LABORATORIES LTD | 31,229.3 | 2.99 | 93,261.6 |
MANKIND PHARMA LTD | 11,641.0 | 8.12 | 94,482.5 |
ZYDUS LIFESCIENCES LTD | 22,247.4 | 3.96 | 88,166.2 |
LUPIN LTD | 22,001.6 | 3.96 | 87,025.8 |
AUROBINDO PHARMA LTD | 30,921.8 | 1.99 | 61,445.9 |
ABBOTT INDIA LTD | 6,243.2 | 10.37 | 64,747.5 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs VENUS REMEDIES 's P/S Ratio
Top 10 Industry Peers | PS Ratio |
---|---|
Min industry PS | 0.61x |
Max industry PS | 16.02x |
Median industry PS | 4.22x |
Average industry PS | 6.22x |
You may also like the below Video Courses